CSI Market
Sign In | Register

Amneal Pharmaceuticals Inc (AMRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AMRX Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Amneal Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AMRX/balance-sheets
https://api.csimarket.com/api/v1/companies/AMRX/fundamentals
https://api.csimarket.com/api/v1/companies/AMRX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent157.40
Restricted Cash and Cash Equivalents, Current0.00
Restricted Cash14.17
Cash & Short-term Investments157.00
Accounts receivable1.88
Due from Related Parties, Current RE9.44
Inventories707.96
Derivatives, Collateral, Regulatory, Deferred33.78
Other Current Assets0.00
Prepaid Expense And Other Assets Current252.16
Total Current Assets2,095.02
Equipment/Property/Plant Net1,206.03
Goodwill net772.47
Intangible Assets1,551.26
Long-term investments8.68
Financial Instruments38.59
Deferred, Prepaid and Other Assets, Noncurrent111.31
Other Assets, Noncurrent402.11
Total Assets5,267.22
Liabilities
Accounts Payable and Accrued Liabilities, Current LI827.00
Estimated Litigation Liability, Current27.53
Long-term Debt, Current Maturities LO23.93
Other Liabilities, Current1,009.37
Discontinued Operation, Liabilities59.00
Total Current Liabilities1,119.84
Long-term debt2,939.43
Total Long-term Debt2,939.43
Estimated Litigation Liability, Noncurrent LI71.66
Other liabilities, Noncurrent605.03
Operating Lease Right Of Use Asset14.47
Operating Lease Liability Noncurrent13.47
Finance Lease Liability Noncurrent54.88
Total Liabilities4,735.96
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,047.64
Retained Earnings / Accumulated Deficit-436.78
Accumulated Other Comprehensive Income-83.08
Other Equity-83.08
Common Stockholder's Equity421.80
Non-controlling interests & other109.45
Total Stockholder's Equity531.26
Liabilities & Stockholder's Equity5,267.22
4 historic quarters locked

Sign in to unlock the full Amneal Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Amneal Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001723128-26-000040

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI